Robert A. Ingram
Board Member
Black Diamond Therapeutics, Inc. (BDTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert A. Ingram
Robert A. Ingram is recorded as Board Member at Black Diamond Therapeutics, Inc. (BDTX). Black Diamond Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that Robert A. Ingram resigned as Chairman of the Board, effective December 13, 2022.
“On December 13, 2022, Robert A. Ingram notified Black Diamond Therapeutics, Inc. (the “Company”) of his intent to resign from the Company’s Board of Directors (the “Board”), including his position of Chairman of the Board and as a member of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-09-25–present
-
2020-09-25–2022-12-13
-
Start not stated–2022-12-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Black Diamond Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark A. Velleca CEO
- Mark A. Velleca, M.D., Ph.D. CEO, Chairman
- Mark Velleca CEO
- Mark Velleca, M.D., Ph.D. CEO, Board Member
- Erika Jones CFO, Chief Accounting Officer, Board Member
- Brent Hatzis-Schoch Board Member
- Elizabeth Buck Board Member
- Kapil Dhingra Board Member
- Melanie Morrison Board Member
- Prakash Raman, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.